Prof Paul Ellis, of Guy's Hospital in London, told the Sunday Express: "This is an incredible drug. We've been looking for something like this for 20 years and it is the first of its kind.
"A drug like this which increases survival with far less side effects is the holy grail of cancer medicine."
The drug consists of a protein which seeks out tumours and a toxin which is only released once inside cancer cells, reducing the damage to healthy tissue.
Trials were carried out at hospitals across the world including three in the UK: the Christis Hospital in Manchester, the Freeman Hospital in Newcastle-upon-Tyne and the Royal Bournemouth General Hospital.
Experts are currently carrying out a further clinical trial on at least 1,000 women in more than 20 countries, including Britain, and results are expected within two years.
Nell Barrie of Cancer Research UK said: "This approach combines two effective treatments but until we have results from larger, longer term trials we won't know for sure how beneficial this could be for patients with this particular type of breast cancer."
Dr Rachel Greig of the Breakthrough Breast Cancer charity said: "This new drug may keep cancer at bay for longer than standard treatments with fewer side effects which crucially could offer patients a better quality of life.
?It?s important to emphasise this drug is still in trials and some years away from potentially being made available on the NHS.?
health websites for women womens-health-concern.org health advice for pregnant women health sites for women
No comments:
Post a Comment